Serotonin receptor imaging: Clinically useful?

Journal of Nuclear Medicine

Volumn 51, Issue 10, 2010, Pages 1495-1498

  Parsey, Ramin V ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

In vivo imaging; Neurotransmitter; Serotonin receptors

Indexed keywords

2' METHOXYPHENYL (N 2' PYRIDINYL) 4 FLUORO BENZAMIDOETHYLPIPERAZINE F 18; 3 AMINO 4 [2 [[DI(METHYL)AMINO]METHYL]PHENYL]SULFANYLBENZONITRILE C 11; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CARBON 11; FLUOROETHYLSPIPERONE F 18; HARMINE C 11; RADIOPHARMACEUTICAL AGENT; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR; TRACER; UNCLASSIFIED DRUG;

DRUG BINDING; ELECTRIC ACTIVITY; EPILEPSY; HUMAN; ISOTOPE LABELING; MAJOR DEPRESSION; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUICIDE; TEMPORAL LOBE EPILEPSY; TREATMENT PLANNING; VALIDITY;

COGNITION DISORDERS; HUMANS; MOLECULAR PROBE TECHNIQUES; NERVOUS SYSTEM DISEASES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, SEROTONIN;

EID: 79851471477     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.068908     Document Type: Review

References (19)

1. Holmes A, Murphy DL, Crawley JN. Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biol Psychiatry. 2003;54:953-959. (Pubitemid 37415031)
2. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. 2009;60:355-366.
3. Nikolaus S, Antke C, Müller H-W. In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders. Behav Brain Res. 2009;204:32-66.
4. Slifstein M, Laruelle M. Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers. Nucl Med Biol. 2001;28:595-608. (Pubitemid 32539407)
5. Innis RB, Cunningham VJ, Delforge J, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27:1533-1539. (Pubitemid 47301451)
6. Pike VW, McCarron JA, Lammertsma AA, et al. Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11C]WAY-100635. Eur J Pharmacol. 1996;301:R5-R7.
7. Sargent P, Rabiner EA, Bhagwagar Z, et al. 5-HT(1A) receptor binding in euthymic bipolar patients using positron emission tomography with [carbonyl-11C]WAY-100635. J Affect Disord. 2010;123:77-80.
8. Drevets WC, Frank E, Price JC, et al. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry. 1999;46:1375-1387.
9. Parsey RV, Oquendo M, Ogden RT, et al. Altered serotonin 1A binding in major depression: A [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry. 2006;59:106-113.
10. Parsey RV, Ogden RT, Miller JM, et al. Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations. Biol Psychiatry. May 22, 2010 [Epub ahead of print].
11. Meyer JH, Ginovart N, Boovariwala A, et al. Elevated monoamine oxidase A levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry. 2006;63:1209-1216. (Pubitemid 44708079)
12. Meyer JH, Wilson AA, Sagrati S, et al. Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence. Arch Gen Psychiatry. 2009;66:1304-1312.
13. Parsey RV, Olvet DM, Oquendo MA, Huang YY, Ogden RT, Mann JJ. Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology. 2006;31:1745-1749. (Pubitemid 44106705)
14. Didelot A, Ryvlin P, Lothe A, Merlet I, Hammers A, Mauguière F. PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy. Brain. 2008;131:2751-2764.
15. Zanardi R, Artigas F, Moresco R, et al. Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study. J Clin Psychopharmacol. 2001;21:53-58. (Pubitemid 32096750)
16. Meyer JH. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J Psychiatry Neurosci. 2007;32:86-102. (Pubitemid 46597955)
17. Nordström AL, Farde L, Nyberg S, Karlsson P, Halldin C, Sedvall G. D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. Am J Psychiatry. 1995;152:1444-1449.
18. Mamo D, Graff A, Mizrahi R, Shammi CM, Romeyer F, Kapur S. Differential effects of aripiprazole on D2, 5-HT2, and 5-HT1A receptor occupancy in patients with schizophrenia: a triple tracer PET study. Am J Psychiatry. 2007;164:1411-1417. (Pubitemid 47461142)
19. Mikhno A, Devanand D, Pelton G, et al. Voxel-based analysis of 11C-PIB scans for diagnosing Alzheimer's disease. J Nucl Med. 2008;49:1262-1269.